Antitumor activity of (-)-alpha-bisabolol-based thiosemicarbazones against human tumor cell lines.
@article{DaSilva2010AntitumorAO, title={Antitumor activity of (-)-alpha-bisabolol-based thiosemicarbazones against human tumor cell lines.}, author={Alan Patricio Da Silva and Manuele V. Martini and Cec{\'i}lia M A de Oliveira and S{\'i}lvio Cunha and Jo{\~a}o Ernesto de Carvalho and Ana L{\'u}cia Tasca Gois Ruiz and Cleuza Conceiç{\~a}o da Silva}, journal={European journal of medicinal chemistry}, year={2010}, volume={45 7}, pages={ 2987-93 } }
47 Citations
Novel R-(+)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines.
- Chemistry, BiologyEuropean journal of medicinal chemistry
- 2014
Synthesis and comparison of antileishmanial and cytotoxic activities of S-(−)-limonene benzaldehyde thiosemicarbazones with their R-(+)-analogues
- ChemistryJournal of Molecular Structure
- 2019
Synthesis of thiophene-thiosemicarbazone derivatives and evaluation of their in vitro and in vivo antitumor activities.
- Chemistry, BiologyEuropean journal of medicinal chemistry
- 2015
Trypanocidal and cytotoxic evaluation of synthesized thiosemicarbazones as potential drug leads against sleeping sickness
- ChemistryMolecular Biology Reports
- 2013
The thiosemicarbazones 2–5 that displayed significant anti-trypanosomal and cytoxicity activities are suggested to have anti-neoplastic and anti-cancer activities.
Thiosemicarbazones as a Potent Anticancer Agents and Their Modes of Action.
- Chemistry, BiologyMini reviews in medicinal chemistry
- 2019
Thiosemicarbazones have a wide clinical antitumor spectrum with efficacy in various tumor types such as leukemia, pancreatic cancer, breast cancer, non-small cell lung cancer, cervical cancer, prostate cancer and bladder cancer and one of the promising areas in which these excellent metal chelators are being developed is their use against cancer.
In vitro and in vivo cytotoxic activity and human serum albumin interaction for a methoxy-styryl-thiosemicarbazone
- Biology, ChemistryInvestigational New Drugs
- 2019
Overall, the interaction HSA:MTSC could provide therapeutic benefits, improving its cytotoxic efficacy and tolerability.
Synthesis, Structural Characterization, and Pro‐apoptotic Activity of 1‐Indanone Thiosemicarbazone Platinum(II) and Palladium(II) Complexes: Potential as Antileukemic Agents
- ChemistryChemMedChem
- 2011
Present findings show that, in U937 cells, 1‐indanone thiosemicarbazones coordinated to palladium(II) were more cytotoxic than those complexed with platinum(II), although the latter were found to be more selective for leukemic cells suggesting that they are promising compounds with potential therapeutic application against hematological malignancies.
Synthesis, molecular modeling, and biological evaluation of novel chiral thiosemicarbazone derivatives as potent anticancer agents.
- Chemistry, BiologyChirality
- 2015
Compound exhibited the most potent activity against HGC-27 as compared with the reference compound, sindaxel, and could be used as a lead compound to search new chiral thiosemicarbazone derivatives as antiproliferative agents.
Synthesis, characterization, and in vitro anti-neoplastic activity of novel vic-dioximes bearing thiosemicarbazone side groups and their mononuclear complexes.
- ChemistryBioorganic chemistry
- 2014
Antitrypanosomal Activity of Novel Benzaldehyde-Thiosemicarbazone Derivatives from Kaurenoic Acid †
- ChemistryMolecules
- 2011
The results show that the structural modifications accomplished enhanced the antitrypanosomal activity of these compounds.
References
SHOWING 1-10 OF 27 REFERENCES
Synthesis and cytotoxicity evaluation of natural alpha-bisabolol beta-D-fucopyranoside and analogues.
- Chemistry, BiologyPhytochemistry
- 2009
Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivatives
- Chemistry, Biology
- 2005
Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity.
- Chemistry, BiologyJournal of inorganic biochemistry
- 2009
Cytotoxicity and structure-activity relationships of four alpha-N-heterocyclic thiosemicarbazone derivatives crystal structure of 2-acetylpyrazine thiosemicarbazone.
- ChemistryBioorganic & medicinal chemistry letters
- 2009
Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
- ChemistryChemical research in toxicology
- 2008
In contrast to other thiosemicarbazones with potent antiproliferative activity, Fe chelation and mobilization rather than free radical generation played a significant role in the cytotoxic effects of the current ligands.
Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives.
- Biology, MedicineEuropean journal of medicinal chemistry
- 2008
2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
- ChemistryJournal of medicinal chemistry
- 2009
This investigation generated the related 2-acetylpyridine thiosemicarbazone (HApT) analogues to examine the influence of the methyl group at the imine carbon and identified structural features necessary to form Fe complexes with potent anticancer activity.
Inhibitory Effect of Thiosemicarbazone Derivatives on Junin Virus Replication In Vitro
- ChemistryAntiviral chemistry & chemotherapy
- 2003
Results from time of addition experiments and viral protein expression assays suggest that tetralone thiosemicarbazone inhibited a late stage in the replicative cycle of JUNV, a arenavirus agent of Argentine haemorrhagic fever.
Synthesis and in vitro antibacterial activity of new steroidal thiosemicarbazone derivatives.
- ChemistryEuropean journal of medicinal chemistry
- 2008
Discovery of new antitubercular oxazolyl thiosemicarbazones.
- Chemistry, BiologyJournal of medicinal chemistry
- 2006
N-(5-cyclobutyl-1,3-oxazol-2-yl)thiosemicarbazone 6q was found to be the most active compound in vitro with minimum inhibitory concentration of 0.05 microg/mL against MTB and MDR-TB and in the in vivo animal model 6q decreased the bacterial load in lung and spleen tissues with 2.1 log 10 protections.